This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.
RECORMON® (epoiten beta) pre-filled syringe is indicated for treatment of:
Treatment of symptomatic anaemia associated with chronic renal failure in adult and paediatric patients.
Prevention of anaemia of prematurity in infants with a birth weight of 750 to 1500 g and a gestational age of less than 34 weeks.
Treatment of symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy.
Increasing the yield of autologous blood from patients in a pre-donation programme. Its use in this indication must be balanced against the reported increased risk of thromboembolic events. Treatment should only be given to patients with moderate anaemia (Hb 10 - 13 g/dl [6.21 - 8.07 mmol/l], no iron deficiency) if blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).
In case of any adverse events or safety queries please contact: [email protected]
If you have a scientific query related to one of Roche's products, please contact us at [email protected]
M-PK-00001196
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.